One of the SELECTIVE SEROTONIN REUPTAKE INHIBITORS formerly used for depression but was withdrawn worldwide in September 1983 because of the risk of GUILLAIN-BARRE SYNDROME associated with its use. (From Martindale, The Extra Pharmacopoeia, 29th ed, p385)
Also Known As:
Zimelidine; H-102-09; Zelmid; Zimeldine Hydrochloride; Zimelidin; Zimelidine Hydrochloride; H 102 09; H10209; Hydrochloride, Zimeldine; Hydrochloride, Zimelidine; 2-Propen-1-amine, 3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridinyl)-, (Z)-